Annual report
7915.TEDINET S100XS06
Period2025-01-01 → 2025-12-31
Filed2026-03-23
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 149
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥194.9bn | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥195.6bn | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥167.7bn | 2023-01-01 → 2023-12-31v | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥194.0bn | 2022-01-01 → 2022-12-31v | Cons. | Net sales IFRS (5-year summary) |
| Revenue | ¥189.3bn | 2021-01-01 → 2021-12-31d | Cons. | Net sales IFRS (5-year summary) |
| Operating income | ¥4.0bn | 2025-01-01 → 2025-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.5bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥3.6bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥6.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥2.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥12.4bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥19.5bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥1.0bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥3.9bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥3.0bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥10.1bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥15.9bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥1.4bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥4.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥250.1bn | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥251.8bn | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥217.9bn | at 2023-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥230.2bn | at 2022-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥209.3bn | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥132.2bn | at 2025-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥136.1bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥117.9bn | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥115.8bn | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥110.9bn | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥115.3bn | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥114.3bn | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥110.9bn | at 2023-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥111.6bn | at 2022-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥98.3bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥39.2bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥51.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥37.9bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥54.3bn | at 2022-12-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥42.3bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥9.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥12.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥1.5bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥12.0bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥18.8bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥13.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥11.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥8.0bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥4.4bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥8.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥9.1bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥12.6bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥1.1bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥2.6bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥21.13 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥79.93 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-61.13 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥203.65 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥318.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥317.16 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,433.56 | at 2025-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,394.01 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,281.64 | at 2023-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,257.47 | at 2022-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,972.89 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 46.1% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.4% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.9% | at 2023-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.5% | at 2022-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 47.0% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 0.9% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.4% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -2.7% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 9.7% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 5,305 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 5,397 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 5,221 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 5,325 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 5,409 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥73.4bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥84.9bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥68.9bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥93.5bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥113.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥5.5bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | −¥2.8bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | −¥2.5bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥968m | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.9bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥3.5bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥9.3bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | −¥3.0bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥6.5bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | −¥4.5bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥10.8bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥156.6bn | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥161.4bn | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥142.9bn | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥159.2bn | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥150.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥80.1bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥80.3bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥76.5bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥81.1bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥84.1bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥90.7bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥85.3bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥17.3bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥30.4bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-63.35 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥135.04 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-91.35 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥217.18 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥124.85 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥124.38 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,614.17 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,699.49 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,729.67 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,836.15 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,711.67 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 48.9% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.3% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.8% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.7% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -3.8% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.1% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.3% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 48,016,000 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 50,855,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 724 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 758 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 720 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 710 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 731 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-01-01 → 2025-12-31 | ¥14.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-12-31 | ¥21.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-01-01 → 2025-12-31 | ¥390m |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-12-31 | −¥1.2bn |
| Reconciling Itemsreconciling | segment assets | at 2025-12-31 | ¥64.0bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | −¥4.3bn |
| Devicesreportable segment | employees | at 2025-12-31 | 750 pure |
| Devicesreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥58.5bn |
| Devicesreportable segment | segment assets | at 2025-12-31 | ¥29.2bn |
| Devicesreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥2.1bn |
| Industrial Materialsreportable segment | employees | at 2025-12-31 | 2520 pure |
| Industrial Materialsreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥76.4bn |
| Industrial Materialsreportable segment | segment assets | at 2025-12-31 | ¥68.4bn |
| Industrial Materialsreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥3.7bn |
| Medical Technologiesreportable segment | employees | at 2025-12-31 | 1335 pure |
| Medical Technologiesreportable segment | revenue | 2025-01-01 → 2025-12-31 | ¥47.1bn |
| Medical Technologiesreportable segment | segment assets | at 2025-12-31 | ¥67.2bn |
| Medical Technologiesreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥2.0bn |
| Other And Corporate R And D Administrativereportable segment | employees | at 2025-12-31 | 700 pure |
| —segment total | revenue | 2025-01-01 → 2025-12-31 | ¥182.0bn |
| —segment total | segment assets | at 2025-12-31 | ¥164.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥7.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-12-31 | ¥196.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-12-31 | ¥186.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-12-31 | ¥8.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-12-31 | ¥9.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-12-31 | ¥11.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-12-31 | −¥731m |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-12-31 | −¥1.1bn |
| Reconciling Itemsreconciling | segment assets | at 2024-12-31 | ¥69.5bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥2.9bn |
| Devicesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥67.6bn |
| Devicesreportable segment | segment assets | at 2024-12-31 | ¥38.8bn |
| Devicesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥1.8bn |
| Industrial Materialsreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥74.2bn |
| Industrial Materialsreportable segment | segment assets | at 2024-12-31 | ¥64.4bn |
| Industrial Materialsreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥4.9bn |
| Medical Technologiesreportable segment | revenue | 2024-01-01 → 2024-12-31 | ¥45.6bn |
| Medical Technologiesreportable segment | segment assets | at 2024-12-31 | ¥68.2bn |
| Medical Technologiesreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥2.4bn |
| —segment total | revenue | 2024-01-01 → 2024-12-31 | ¥187.3bn |
| —segment total | segment assets | at 2024-12-31 | ¥171.4bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥9.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-12-31 | ¥196.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-12-31 | ¥182.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥8.3bn |
| Devicesreportable segment | employees | at 2025-12-31 | 158 pure |
| Industrial Materialsreportable segment | employees | at 2025-12-31 | 254 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,217
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高 居 健 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)辻 知 美 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Text · Plus | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表注記11. | |
| Reference2 kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表注記11. | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)高 居 健 一 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)辻 知 美 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)関係会社株式（Nissha Medical International, Inc.）の評価 | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)注記事項(重要な会計上の見積り) | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales IFRS (5-year summary) | Prior4YearDuration | 189285000000 | JPY |
| Net sales IFRS (5-year summary) | Prior3YearDuration | 193963000000 | JPY |
| Net sales IFRS (5-year summary) | Prior2YearDuration | 167726000000 | JPY |
| Net sales IFRS (5-year summary) | Prior1YearDuration | 195598000000 | JPY |
| Net sales IFRS (5-year summary) | CurrentYearDuration | 194898000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior4YearDuration | 19499000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior3YearDuration | 12373000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior2YearDuration | -2762000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 6202000000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYearDuration | 3551000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior4YearDuration | 15859000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior3YearDuration | 10140000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior2YearDuration | -2988000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 3851000000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYearDuration | 1001000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior4YearDuration | 18102000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior3YearDuration | 15949000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior2YearDuration | 3673000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 11554000000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | CurrentYearDuration | 4455000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior4YearInstant | 98278000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior3YearInstant | 111553000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior2YearInstant | 110913000000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 114297000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |